Last week the Northwest Biotherapeutics Inc (OTCMKTS:NWBO) stock had been in the middle of a downward spiral and had clocked losses of as much as 10%.
Trading Data
On Monday, NWBO stock jumped 3.83% at $0.95 with more than 1.99 million shares, compared to its average volume of 1.70 million shares. The stock has moved within a range of $0.8686 – 0.9500 after opening trade at $0.8950.
Recent Developments
However, the stock managed to make a bit of a comeback on Monday and ended the day with gains of as much as 4%. There was no news about the company on Monday but in this context it might be a good time to take a look at Northwest’s financial results for the third quarter which were announced last Monday.
The company had announced that it managed to generate earnings to the tune of as much as $45.5 million for the quarter. Northwest also noted that profits worked out to 1 cent a share for the quarter. The revenues for the quarter came in at $350,000.
On the other hand, it might also be a good time to note that back on October 28 this year the company had announced that it had managed to hit two key milestones with regards to the development of its solid tumour cancer medicine DCVax. The product is being manufactured at the facility located in Sawston, United Kingdom and remains the most important project for Northwest at this point in time.
Technical Data
NWBO stock is below the 20-Day and 50-Day Moving averages of $1.06 and $1.17 respectively. However, the stock is above the 200-Day moving average of $1.37. The stock is down 17% in the past 3-month.
